MARIO
FERNÁNDEZ RUIZ
Profesor asociado de Ciencias de la Salud
![Foto de MARIO](/img/nophoto.png)
![Foto de Hospital Clínico San Carlos de Madrid](/img/noimage_org.png)
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (22)
2023
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
-
Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients
Transplantation Reviews
-
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Viruses, Vol. 15, Núm. 7
2022
2021
-
Early Stepdown from Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies
Open Forum Infectious Diseases, Vol. 8, Núm. 6
-
Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a spanish multicenter cohort
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 5
2020
-
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 730-737
-
Factors associated with the development of septic shock in patients with candidemia: A post hoc analysis from two prospective cohorts
Critical Care, Vol. 24, Núm. 1
-
Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort
American Journal of Transplantation, Vol. 20, Núm. 2, pp. 451-462
2019
-
Candidemia in solid organ transplant recipients in Spain: Epidemiological trends and determinants of outcome
Transplant Infectious Disease, Vol. 21, Núm. 6
-
Usefulness of guideline recommendations for prognosis in patients with candidemia
Medical mycology, Vol. 57, Núm. 6, pp. 659-667
2018
-
T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: A prospective pilot study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv6-iv12
-
T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv13-iv19
2017
-
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11
-
Is routine ophthalmoscopy really necessary in candidemic patients?
PLoS ONE, Vol. 12, Núm. 10
-
No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins
Diagnostic Microbiology and Infectious Disease, Vol. 88, Núm. 2, pp. 141-144
2016
-
Propensity score analysis of the role of initial antifungal therapy in the outcome of Candida glabrata bloodstream infections
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 6, pp. 3291-3300
2015
-
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9
-
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
Journal of Infection, Vol. 71, Núm. 3, pp. 385-394
-
Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10